Open Access iconOpen Access

REVIEW

crossmark

Ferroptosis molecular inducers: A future direction for malignant tumor chemotherapy

ZIQIAN WANG1,2,#, YAQI LI1,2,#, DONGYANG WANG1,2, YINGQIANG SHEN1,3,4,5,*

1 State Key Laboratory of Oral Diseases, Chengdu, 610041, China
2 West China School of Stomatology, Sichuan University, Chengdu, 610041, China
3 National Clinical Research Center for Oral Diseases, Chengdu, 610041, China
4 Chinese Academy of Medical Sciences Research Unit of Oral Medicine of Carcinogenesis and Management, Chengdu, 610041, China
5 West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China

* Corresponding Author: Yingqiang Shen, email
# These two authors contribute equally to this work

(This article belongs to the Special Issue: Single Cell Technologies and Molecular Mechanisms of Diseases)

BIOCELL 2022, 46(7), 1599-1611. https://doi.org/10.32604/biocell.2022.018530

Abstract

Iron-dependent ferroptosis is a form of cell death dependent on iron levels. Cells that undergo ferroptosis have glutathione (GSH) deficiency, reduced Glutathione peroxidase-4 (GPX4) activity and intracellular lipid peroxidation, Mitochondria, lysosomes and many signal pathways are involved in the regulation of ferroptosis. More importantly, many tumor cells resistant to other cell death methods exhibit sensitivity to ferroptosis. Moreover, over recent years, a number of ferroptosis-induced drugs have been recommended for the treatment of malignant tumors. Therefore, the study of ferroptosis is of great significance for future cancer treatments. In this review, we discussed the metabolic process of ferroptosis, the role of different organelles, the typical signaling pathways involved in ferroptosis, as well as natural and synthetic compounds that can induce ferroptosis, aiming to point out new conceptual avenues for utilizing ferroptosis in future cancer treatments.

Keywords


Cite This Article

APA Style
WANG, Z., LI, Y., WANG, D., SHEN, Y. (2022). Ferroptosis molecular inducers: A future direction for malignant tumor chemotherapy. BIOCELL, 46(7), 1599-1611. https://doi.org/10.32604/biocell.2022.018530
Vancouver Style
WANG Z, LI Y, WANG D, SHEN Y. Ferroptosis molecular inducers: A future direction for malignant tumor chemotherapy. BIOCELL . 2022;46(7):1599-1611 https://doi.org/10.32604/biocell.2022.018530
IEEE Style
Z. WANG, Y. LI, D. WANG, and Y. SHEN "Ferroptosis molecular inducers: A future direction for malignant tumor chemotherapy," BIOCELL , vol. 46, no. 7, pp. 1599-1611. 2022. https://doi.org/10.32604/biocell.2022.018530



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 2130

    View

  • 1003

    Download

  • 1

    Like

Share Link